Medtronic (XSWX:MDT) Cash Flow for Dividends: CHF-2,887 Mil (TTM As of Apr. 2026)


XSWX:MDT Medtronic PLC XSWX:MDT
21 GF Score
Price CHF65.29
GF Value CHF80.97
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Cash Flow for Dividends?

Medtronic XSWX:MDT +1.21% 21 Cash Flow for Dividends is CHF-2,887 Mil as of Apr. 2026. GuruFocus rates XSWX:MDT with a GF Score™ of 21/100 and a GF Value™ of CHF80.97 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Medtronic's cash flow for dividends for the three months ended in Apr. 2026 was CHF-715 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Apr. 2026 was CHF-2,887 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Medtronic's quarterly payment of dividends declined from Oct. 2025 (CHF-726 Mil) to Jan. 2026 (CHF-719 Mil) and declined from Jan. 2026 (CHF-719 Mil) to Apr. 2026 (CHF-715 Mil).

Medtronic's annual payment of dividends declined from Apr. 2024 (CHF-3,336 Mil) to Apr. 2025 (CHF-2,992 Mil) and declined from Apr. 2025 (CHF-2,992 Mil) to Apr. 2026 (CHF-2,866 Mil).

Medtronic Cash Flow for Dividends Related Terms

Medtronic Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Medtronic's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Cash Flow for Dividends Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,196.94 -3,248.98 -3,335.69 -2,992.15 -2,866.08

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -747.83 -727.00 -725.73 -719.14 -715.14
XSWX:MDT
21GF Score
Medtronic PLC XSWX:MDT
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-2,887 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of CHF-2,887 Mil mean?
Medtronic (XSWX:MDT) has a Cash Flow for Dividends of CHF-2,887 Mil as of Apr. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Medtronic and its competitors.
Is Medtronic's Cash Flow for Dividends too high?
Medtronic's current Cash Flow for Dividends is CHF-2,887 Mil. Overall, Medtronic has a GF Score™ of 21/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Cash Flow for Dividends compare to SYK and BSX?
Medtronic's Cash Flow for Dividends of CHF-2,887 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Medtronic and its competitors. Medtronic's current Cash Flow for Dividends is CHF-2,887 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (XSWX:MDT) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF80.97, compared to a current price of CHF65.29 — trading 19.4% below its estimated fair value. The current Cash Flow for Dividends is CHF-2,887 Mil. Medtronic's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Medtronic (XSWX:MDT), the current Cash Flow for Dividends is CHF-2,887 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (XSWX:MDT) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of CHF65.29 is trading 19.4% below its estimated GF Value™ of CHF80.97. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for XSWX:MDT:

  • Cash Flow for Dividends: CHF-2,887 Mil
  • GF Value™: CHF80.97 vs. price of CHF65.29 (19.4% below fair value)
  • GF Score™: 21/100 with 3 warning signs

No single metric tells the full story. See the XSWX:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
21GF Score

Get the complete analysis for XSWX:MDT

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF65.29
Price
CHF80.97
GF Value